Esperion Therapeutics
Latest round
- Series A
Last raised
- May 2008
Total raised
- $45M
Investors
- 9
About Esperion Therapeutics
Esperion Therapeutics, Inc.Esperion Therapeutics specializes in creating treatments for cardiovascular conditions and is headquartered in Ann Arbor, US.75 million shares at USD 100 each.Esperion Therapeutics, Inc. specializes in the development of innovative treatments for cardiovascular disease, offering two core products that have gained regulatory approval in both the United States and Europe. These treatments utilize a unique mechanism of action targeting ACLY biology, marking a significant advancement in cardiovascular disease management. The company's pioneering work has led to the introduction of the first ACLY inhibitor to the market, which is aimed at addressing the unmet needs of patients suffering from life-threatening cardiovascular conditions.47 mn for the same year.Esperion Therapeutics plans to launch new products targeting cardiovascular diseases with anticipated releases in the coming years, although specific dates are not disclosed. The company aims to expand its reach into new markets, particularly focusing on regions with unmet treatment needs.
Who invested in Esperion Therapeutics
9 investors across 2 rounds
See all investors in Esperion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Esperion Therapeutics
Who invested in Esperion Therapeutics?
Esperion Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Esperion Therapeutics raised?
Esperion Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Esperion Therapeutics last raise money?
Esperion Therapeutics's most recent round on record is a Series A, in May 2008.
What does Esperion Therapeutics do?
Esperion Therapeutics is a pharmaceuticals company.
Where is Esperion Therapeutics headquartered?
Esperion Therapeutics is headquartered in Ann Arbor, US.
Which VCs invest in companies like Esperion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Esperion Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Esperion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.